Sen. Richard Durbin (D-IL) has demanded that the acting head of the Food and Drug Administration take “decisive” action on vaping or quit. Durbin wants acting FDA head Ned Sharpless to warn schools about vaping, ban non-tobacco flavors and pull unapproved devices from stores. (CNBC)

Stephen Hahn, executive at M.D. Anderson Cancer Center, is the frontrunner to lead the FDA on a permanent basis. Hahn, chief medical executive at the Houston cancer center, reportedly met with President Donald Trump this week about the position. (Politico)

Purdue Pharma is in talks with the Justice Department to resolve criminal probes. The DOJ is investigating Purdue’s failure to report doctors who illegally prescribed opioids and the company’s order-monitoring system. A deal to end the probes would likely include a large fine. (Wall Street Journal)

Google has banned ads for “unproven or experimental medical techniques.” The policy means the company will not accept ads that have no established scientific basis. It was spurred by the increase in advertisements for stem cell clinics that claim their treatments can help with serious conditions. (Washington Post)

CVS has hired a Fitbit executive to lead its consumer health products unit.  Adam Pellegrini, previously general manager and SVP for Fitbit Health Solutions, will join CVS as SVP of transformation consumer health products. Fitbit COO of health solutions Amy McDonough will replace Pellegrini. (CNBC)